Wall Street Journal Sept. 27
These are the most popular stories from the Wall Street Journal. These stories have not been verified and we cannot vouch their accuracy.
U.S. Antitrust enforcers will bar Hess CEO John Hess joining the board at Chevron in a deal that approves a $53 Billion tie-up between Hess & Chevron.
Accident investigators from the National Transportation Safety Board urged Boeing and the Federal Aviation Administration to fix a potential safety hazard in about 350 Boeing 737 models that are currently flying.
DirecTV has advanced in its talks to buy satellite TV rival Dish. A deal could be completed as early as Monday.
On Thursday, the U.S. FDA granted approval to Bristol-Myers Squibb’s schizophrenia drug Cobenfy (also known as KarXT).
Cassava Sciences, a developer of Alzheimer's drugs, agreed on Thursday to pay $40m to settle claims by regulators that the company misled investors regarding results from a clinical study that showed promise with its drug Simufilam.
Newsmax has announced that it has settled with Smartmatic in a lawsuit filed by the company over false allegations that the voting technology company had helped to rig the presidential election of 2020. (Compiled from Bengaluru Newsroom)
(source: Reuters)
